Case Studies

U.S. Navy’s 250th Anniversary

Inhance and Access TCA worked together to create an interactive temporary museum celebrating the Navy’s 250 years of history.

Insmed’s 80X80 CHEST Exhibit

CHEST 2025 in Chicago was Insmed’s marquee professional moment: the first major respiratory congress since approval of BRINSUPRI as the first and only treatment for non-cystic fibrosis bronchiectasis.

Insmed’s 20×20 Medical Affairs Exhibit

At CHEST, Insmed aimed to capture not only the audience’s curiosity about the science but also to improve the exhibit’s visual appeal.

WSP

After being acquired by WSP, Power Engineers needed a full rebrand for DistribuTECH—see how Access refreshed their 20’ x 20’ exhibit with updated branding, new graphics, and lighting upgrades.

Sierra Nevada Corporation

Exhibitors in the defense industry need to plan experiences and engagement strategies for their attendees while they engage with many levels of clients—from engineers to politicians.

Boehringer Ingelheim at Art Basel

At Miami’s Art Basel, Boehringer Ingelheim launched an activation that emphasized the importance of complete testing for and early diagnosis of chronic kidney disease.

Akebia

Founded in 2007, Akebia focuses on achieving better outcomes for people with kidney disease. At ASN, Akebia introduced a new drug, VAFSEO®, based on Nobel-prize-winning science.

PRN Pharmacal

PRN® is dedicated to leading the industry in research and development of niche products and drug therapies that address overlooked areas of pet and animal health.

Boehringer Ingelheim Bridges the Gap

Boehringer Ingelheim’s exhibit at ATS sought to represent the unfinished bridge between the existing treatment for Interstitial Lung Disease and new drug innovation.

IO Biotech: Breaking Out from the Crowd

IO Biotech’s mission is to “Break Boundaries and Ignite Change.” As a first-time exhibitor at ASCO 2025, the company sought to assert its identity as a bold innovator in cancer immunotherapy.

Nationwide Targets Another Market

Nationwide Pet Insurance and Access have been partners since 2011 — but in 2025, this partnership allowed us to explore a market that was previously unavailable to them.

Boehringer Ingelheim’s ATS Sponsorship

See how Boehringer Ingelheim placed sustainability front and center with their sponsorship for ATS.

Sumitomo: Two Brands, One Exhibit

Sumitomo’s exhibit at the American Urological Association had to showcase two different products from two different companies — and feature distinct themes for each brand.

Boehringer Ingelheim’s Rube Goldberg Machine

Boehringer Ingelheim showcased the unique path of GPP with an exhibit inspired by Rube Goldberg.

Abivax

Abivax, founded in Paris in 2013, was looking to commercialize their lead product candidate, obefazimod, in the US and EMEA simultaneously. See how they presented their solution with the same exhibit on two continents.

Boehringer Ingelheim Sounds the Alarm

Boehringer Ingelheim’s disease state exhibit, “Sound the Alarm,” explores the warning signs of Interstitial Lung Disease.

PCMA

PCMA is the world’s largest community for business events strategists, providing senior-level education, networking, and market intelligence for the global business events industry.

Teva at ACR

At the American College of Rheumatology (ACR), Teva presented its latest works of art: SIMLANDI®, an FDA-approved interchangeable biosimilar to Humira®, and SELARSDI®, an FDA-approved interchangeable biosimilar to Stelara®.

NAACP

NAACP needed to create an experience at the six-day ACT-SO event designed to provide recognition to young people who can demonstrate academic, scientific, and artistic achievement, allowing young people to gain recognition equal to that often achieved by entertainers and athletes.

Teva

At the American Psychiatric Association, Teva launched an important new product: UZEDY®, a treatment for schizophrenia that aims to decrease risk of relapse.

Boehringer Ingelheim at ASCO 2024

Boehringer Ingelheim set out to bring real, tangible change to its exhibition practices and demonstrate its commitment to its Sustainable Development for Generations efforts.

Lantheus

Lantheus pioneers next-generation solutions—from precision diagnostics to radiopharmaceuticals—that help improve outcomes and lives.

Diablo

Diablo is the industry leader of solution-oriented products for trade professionals, including cutting tools.

Hamilton

Hamilton, the largest automated liquid handling company in the world, worked with Access to showcase multiple business units with an open exhibit design.

Transmedics Leadership Forum

First, TransMedics created a bold exhibit experience as ISHLT. Next, they hosted a Leadership Forum to further educate decision-makers about organ transplantation.

Insmed

Insmed needed a creative way to showcase their ARIKAYCE® therapy system. See how Access helped them create engaging exhibits using creative imagery—including a vampire display and a hovering tornado.

Sumitomo

Sumitomo Pharma America (SMPA), is a science-based, technology-driven biopharmaceutical company. They needed an exhibit that would provide an environment for oncologists to learn more about new therapies.

Regis

Regis Corporation is the industry’s global leader in beauty salons and cosmetology education, owning or franchising more than 5,200 locations worldwide. After more then two decades as an Access partner, they recently refreshed their look with a new, interactive exhibit.

Boehringer-Ingelheim’s Cave-Dwelling Dragon

At AAD 2023, with the approval of Spevigo to treat GPP, Boehringer Ingelheim wanted a launch exhibit that was as powerful as the disease state exhibit. Connecting the pain to the treatment required a powerful image, a powerful metaphor, and a powerful statement: Disrupt the Fury.

TransMedics

TransMedics works on streamlining organ transportation and doubling the inventory of available organs for transplant. They needed an exhibit that could tell the whole story: the journey of the organ from the donor to the transplant surgeon.

Boehringer-Ingelheim Modular Exhibits

Before the start of COVID, BI had invested in a significant inventory of beMatrix components. When congresses resumed in 2022, BI developed a plan to use the modular solution to promote a single drug at a variety of shows.

Boehringer-Ingelheim

BI, a pharmaceutical company, wanted to educate professionals about Generalized Pustular Psoriasis (GPP). Sculptor Bart Hess’s artwork showcased the various symptoms described by people with GPP, and Access helped create a powerful, award-winning exhibit experience.

Access Relaunch

The pandemic interrupted Access’ launch of its new brand identity. This exhibit, designed in 2019, finally made it to the show floor to continue the launch.

Pharmacosmos

During the pandemic, Pharmacosmos’ MONOFERRIC was approved by the FDA for use in the US. Though the exhibits industry was facing constraints, they were finally able to show off the product with this inline exhibit.

Acceleron

Acceleron focuses on harnessing the power of the TGF-beta protein superfamily, the target-rich area of biology behind the body’s remarkable capacity for cellular growth and repair.

Nationwide

Global insurance company, highlighting pet insurance at this conference. 

Legend Biotech

A global, clinical-stage biotechnology company developing and manufacturing novel therapies.

ONO

ONO is focused on oncology, immunology, neurology, and specialty domains with high medical needs. A 300-year-old Japanese company expanded to North America in 2019 after establishing itself in Asia. 

FIRST

FIRST provides science and technology education and opportunities for children in grades K-12.

Kala Pharmaceuticals

Kala Pharmaceuticals was launching its first product, INVELTYS, at a key medical meeting, American Society for Cataract and Refractive Surgery (ASCRS).

Dermira

Dermira delivers new therapies to patients living with chronic skin conditions, believing that innovation and product development in medical dermatology lags behind other therapeutic areas.

Neurocrine Biosciences

Neurocrine, a San Diego-based biotech company, developed INGREZZA, the first product to treat tardive dyskinesia.

Teknor Apex

A material science company that develops polymers for a variety of products in a plethora of industries. The company is an important supplier of raw materials—and no one knows who they are!

THINK Surgical

THINK Surgical develops, manufactures, and markets the only active robotic surgical system for orthopedic surgery.

Candela

Candela unveils new corporate identity and showcases a full line of innovative medical aesthetic devices at AAD.

Jazz Pharmaceuticals

Jazz Pharmaceuticals wanted to create a buzz about their yet-to-be approved sleep drug to treat narcolepsy.

Access TCA: WE BUILD

At Event Marketer’s Experiential Marketing Summit, Access’s goal was to showcase its biggest strength: “We Build!”